Brain Cancer Trial, Recruiting (NCT06995313)

Brain Cancer Trial, Recruiting NCT06995313 Sponsor: University Health Network, Toronto Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06995313 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with hemianopia (a condition where vision is lost in half of the visual field in one or both eyes), confirmed through specific vision testing including microperimetry
People whose vision loss has been present for more than 6 months
People between 18 and 90 years old
People who are able to follow visual and audio instructions during the tasks and training involved in the trial

Who may not be able to join:

People who are currently receiving, or have previously received, treatment aimed at improving low vision or visual rehabilitation
People who have other eye diseases or conditions affecting their eyes
People who have other serious health conditions unrelated to their hemianopia
People whose eyes have clouding or other issues that would prevent accurate microperimetry (specialised vision) testing from being carried out
People who are unable to complete the required tests and training involved in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: MONICA Daibert Nido, Assistant, University Healt Network

Phone: 4166035800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06995313

Sponsor: University Health Network, Toronto

Phase: Not Applicable

Status: Recruiting

Condition: Brain Cancer

Trial contact: 4166035800

More information: https://clinicaltrials.gov/study/NCT06995313

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with hemianopia (a condition where vision is lost in half of the visual field in one or both eyes), confirmed through specific vision testing including microperimetry
People whose vision loss has been present for more than 6 months
People between 18 and 90 years old
People who are able to follow visual and audio instructions during the tasks and training involved in the trial

Who may not be able to join:

People who are currently receiving, or have previously received, treatment aimed at improving low vision or visual rehabilitation
People who have other eye diseases or conditions affecting their eyes
People who have other serious health conditions unrelated to their hemianopia
People whose eyes have clouding or other issues that would prevent accurate microperimetry (specialised vision) testing from being carried out
People who are unable to complete the required tests and training involved in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Health Network, Toronto

Registry

ClinicalTrials.gov

Start date

8 December 2021

Est. completion

8 July 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Retinal sensitivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov